GLA - New-wiki

Novel	Interactant Symbol	Name	Associated Pathways Hide	Binding Drugs Hide	Associated Diseases Hide
Novel	ANKRD30A	ankyrin repeat domain 30A
Novel	CCR2	C-C motif chemokine receptor 2	Beta defensins Chemokine receptors bind chemokines G alpha (i) signalling events Interleukin-10 signaling	INCB3284 CCX915 Plozalizumab
Novel	COL4A5	collagen type IV alpha 5 chain	Collagen degradation Collagen degradation Extracellular matrix organization Collagen biosynthesis and modifying enzymes Signaling by PDGF Assembly of collagen fibrils and other multimeric structures Integrin cell surface interactions Integrin cell surface interactions Anchoring fibril formation Crosslinking of collagen fibrils Laminin interactions Laminin interactions Non-integrin membrane-ECM interactions ECM proteoglycans NCAM1 interactions Collagen chain trimerization Regulation of expression of SLITs and ROBOs		Alport syndrome
Novel	DUSP6	dual specificity phosphatase 6	RAF-independent MAPK1/3 activation ERKs are inactivated Negative regulation of MAPK pathway Signaling by MAPK mutants
Novel	GPR17	G protein-coupled receptor 17	Leukotriene receptors G alpha (q) signalling events P2Y receptors G alpha (i) signalling events
Novel	GUCY2F	guanylate cyclase 2F, retinal	Inactivation, recovery and regulation of the phototransduction cascade
Novel	HNRNPH2	heterogeneous nuclear ribonucleoprotein H2	mRNA Splicing - Major Pathway Processing of Capped Intron-Containing Pre-mRNA
Novel	MORF4L2	mortality factor 4 like 2	HATs acetylate histones
Novel	NAP1L3	nucleosome assembly protein 1 like 3
Novel	NOSTRIN	nitric oxide synthase trafficking	NOSTRIN mediated eNOS trafficking
Novel	PDE6B	phosphodiesterase 6B	Activation of the phototransduction cascade Activation of the phototransduction cascade Inactivation, recovery and regulation of the phototransduction cascade Ca2+ pathway Ca2+ pathway	Caffeine Trapidil	Congenital stationary night blindness (CSNB), including: CSNB type 1 (CSNB1); CSNB type 2 (CSNB2); CSNB autosomal dominant (CSNBAD); Oguchi disease/ CSNB Oguchi type (CSNBO) Retinitis pigmentosa (RP)
Novel	PLP1	proteolipid protein 1			Hereditary spastic paraplegia (SPG) Hypomyelinating leukodystrophy (HLD); Pelizaeus-Merzbacher disease (PMD)
	TERT	telomerase reverse transcriptase	Telomere Extension By Telomerase Formation of the beta-catenin:TCF transactivating complex	Zidovudine Grn163l Tertomotide	Cri du chat syndrome; Cat cry syndrome; Chromosme 5p deletion syndrome

Search Results for: GLA